Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Asthma

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    September 2018
  1. DOMINGO C, Palomares O, Sandham DA, Erpenbeck VJ, et al
    The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation.
    Respir Res. 2018;19:189.
    PubMed     Text format     Abstract available


  2. KIRENGA BJ, Mugenyi L, de Jong C, Lucian Davis J, et al
    The impact of HIV on the prevalence of asthma in Uganda: a general population survey.
    Respir Res. 2018;19:184.
    PubMed     Text format     Abstract available


  3. ZIYAB AH, Mukherjee N, Kurukulaaratchy RJ, Zhang H, et al
    Leptin receptor gene polymorphisms and sex modify the association between acetaminophen use and asthma among young adults: results from two observational studies.
    Respir Res. 2018;19:179.
    PubMed     Text format     Abstract available


  4. TONGA KO, King GG, Farah CS, Thamrin C, et al
    Steroid insensitive fixed airflow obstruction is not related to airway inflammation in older non-smokers with asthma.
    Respir Res. 2018;19:176.
    PubMed     Text format     Abstract available


  5. WATANABE M, Nakamoto K, Inui T, Sada M, et al
    Serum sST2 levels predict severe exacerbation of asthma.
    Respir Res. 2018;19:169.
    PubMed     Text format     Abstract available


  6. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR).
    Respir Res. 2018;19:168.
    PubMed     Text format     Abstract available


    August 2018
  7. MATUCCI A, Vultaggio A, Danesi R
    The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review.
    Respir Res. 2018;19:154.
    PubMed     Text format     Abstract available


  8. BURBANK AJ, Todoric K, Steele P, Rosen J, et al
    Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics.
    Respir Res. 2018;19:152.
    PubMed     Text format     Abstract available


  9. ATANASOVA KR, Reznikov LR
    Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.
    Respir Res. 2018;19:149.
    PubMed     Text format     Abstract available


    July 2018
  10. BARDSLEY G, Daley-Yates P, Baines A, Kempsford R, et al
    Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
    Respir Res. 2018;19:133.
    PubMed     Text format     Abstract available


    June 2018
  11. PHILPOTT CM, Erskine S, Hopkins C, Kumar N, et al
    Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
    Respir Res. 2018;19:129.
    PubMed     Text format     Abstract available


  12. KHO AT, McGeachie MJ, Moore KG, Sylvia JM, et al
    Circulating microRNAs and prediction of asthma exacerbation in childhood asthma.
    Respir Res. 2018;19:128.
    PubMed     Text format     Abstract available


  13. XIN T, Chen M, Duan L, Xu Y, et al
    Interleukin-32: its role in asthma and potential as a therapeutic agent.
    Respir Res. 2018;19:124.
    PubMed     Text format     Abstract available


  14. MATUCCI A, Vultaggio A, Maggi E, Kasujee I, et al
    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
    Respir Res. 2018;19:113.
    PubMed     Text format     Abstract available


    May 2018
  15. CLOOTS RHE, Poynter ME, Terwindt E, Lamers WH, et al
    Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma.
    Respir Res. 2018;19:98.
    PubMed     Text format     Abstract available


  16. BELVISI MG, Baker K, Malloy N, Raemdonck K, et al
    Modelling the asthma phenotype: impact of cigarette smoke exposure.
    Respir Res. 2018;19:89.
    PubMed     Text format     Abstract available


    April 2018
  17. BLOECHLIGER M, Reinau D, Spoendlin J, Chang SC, et al
    Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
    Respir Res. 2018;19:75.
    PubMed     Text format     Abstract available


    March 2018
  18. WANG J, Lv H, Luo Z, Mou S, et al
    Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
    Respir Res. 2018;19:47.
    PubMed     Text format     Abstract available


  19. PADILLA-GALO A, Olveira C, Fernandez de Rota-Garcia L, Marco-Galve I, et al
    Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.
    Respir Res. 2018;19:43.
    PubMed     Text format     Abstract available


  20. PARK HY, Lee SY, Kang D, Cho J, et al
    Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
    Respir Res. 2018;19:36.
    PubMed     Text format     Abstract available


    January 2018
  21. MAHMUTOVIC PERSSON I, Menzel M, Ramu S, Cerps S, et al
    IL-1beta mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation.
    Respir Res. 2018;19:16.
    PubMed     Text format     Abstract available


  22. LARSSON K, Stallberg B, Lisspers K, Telg G, et al
    Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).
    Respir Res. 2018;19:12.
    PubMed     Text format     Abstract available


  23. USMANI OS, Lavorini F, Marshall J, Dunlop WCN, et al
    Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.
    Respir Res. 2018;19:10.
    PubMed     Text format     Abstract available


    December 2017
  24. BAO A, Yang H, Ji J, Chen Y, et al
    Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model.
    Respir Res. 2017;18:216.
    PubMed     Text format     Abstract available


  25. VARGAS A, Boivin R, Cano P, Murcia Y, et al
    Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Respir Res. 2017;18:207.
    PubMed     Text format     Abstract available


  26. KASTELEYN MJ, Bonten TN, de Mutsert R, Thijs W, et al
    Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study.
    Respir Res. 2017;18:205.
    PubMed     Text format     Abstract available


  27. WANG G, Zhang X, Zhang HP, Wang L, et al
    Corticosteroid plus beta2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
    Respir Res. 2017;18:203.
    PubMed     Text format     Abstract available


    November 2017
  28. LO CY, Michaeloudes C, Bhavsar PK, Huang CD, et al
    Reduced suppressive effect of beta2-adrenoceptor agonist on fibrocyte function in severe asthma.
    Respir Res. 2017;18:194.
    PubMed     Text format     Abstract available


  29. ZHANG L, Zhang J, Gao P
    The potential of interleukin-37 as an effective therapeutic agent in asthma.
    Respir Res. 2017;18:192.
    PubMed     Text format     Abstract available


  30. DESCHILDRE A, Pichavant M, Engelmann I, Langlois C, et al
    Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients.
    Respir Res. 2017;18:191.
    PubMed     Text format     Abstract available


  31. PEREZ-DE-LLANO L, Cosio BG
    Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
    Respir Res. 2017;18:183.
    PubMed     Text format     Abstract available


    September 2017
  32. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Text format     Abstract available


    August 2017
  33. BLAIS CM, Davis BE, Cockcroft DW
    The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
    Respir Res. 2017;18:146.
    PubMed     Text format     Abstract available


    July 2017
  34. DEMARCHE SF, Schleich FN, Paulus VA, Henket MA, et al
    Is it possible to claim or refute sputum eosinophils >/= 3% in asthmatics with sufficient accuracy using biomarkers?
    Respir Res. 2017;18:133.
    PubMed     Text format     Abstract available


    April 2017
  35. BAKER K, Raemdonck K, Snelgrove RJ, Belvisi MG, et al
    Characterisation of a murine model of the late asthmatic response.
    Respir Res. 2017;18:55.
    PubMed     Text format     Abstract available


    February 2017
  36. BOULAY ME, Henry C, Bosse Y, Boulet LP, et al
    Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals.
    Respir Res. 2017;18:33.
    PubMed     Text format     Abstract available


    January 2017
  37. AUGUSTO LS, Silva GC, Pinho JF, Aires RD, et al
    Vascular function in asthmatic children and adolescents.
    Respir Res. 2017;18:17.
    PubMed     Text format     Abstract available


  38. TOPALOVIC M, Exadaktylos V, Troosters T, Celis G, et al
    Non-linear parameters of specific resistance loops to characterise obstructive airways diseases.
    Respir Res. 2017;18:9.
    PubMed     Text format     Abstract available


    November 2016
  39. KRAEMER R, Smith HJ, Sigrist T, Giger G, et al
    Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach.
    Respir Res. 2016;17:154.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: